Tumour compartment transcriptomics demonstrates the activation of inflammatory and odontogenic programmes in human adamantinomatous craniopharyngioma and identifies the MAPK/ERK pathway as a novel therapeutic target. (2018)
Attributed to:
Molecular and Cellular Mechanisms Underlying Pituitary Tumours
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1007/s00401-018-1830-2
PubMed Identifier: 29541918
Publication URI: http://europepmc.org/abstract/MED/29541918
Type: Journal Article/Review
Volume: 135
Parent Publication: Acta neuropathologica
Issue: 5
ISSN: 0001-6322